drugset / Trial / NCT07443059
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal insufficiency and matched participants with normal renal function.
Timeline
- Start
- 2026-04-13
- Primary completion
- 2026-12-03
- Completion
- 2027-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zovaglutide | Unknown | — | Subcutaneous |